Skip to main content

Table 2 Comparison of PMI and outcomes between two groups

From: CT-determined sarcopenia is associated with neutropenia in patients undergoing hyperthermic intraperitoneal chemotherapy for gastrointestinal cancer

Characteristic

Sarcopenia

(nā€‰=ā€‰37, 35.9%)

No sarcopenia

(nā€‰=ā€‰66, 64.1%)

p

CT-to-surgery interval (days)

6 (5, 9.5)

5 (3, 9)

0.24

PMI (mm2/m2)

ā€ƒMale

440.37 (387.74, 505.34)

658.32 (601.86, 760.76)

ā€‰<ā€‰0.001**

ā€ƒFemale

308.90 (253.53, 339.47)

489.01 (446.94, 611.14)

ā€‰<ā€‰0.001**

Abdominal complications

3

5

0.16

Postoperative stay (days)

10 (8, 11)

9 (8, 10.25)

0.16

Leukopenia

ā€ƒ7Ā days after surgery

1

5

0.42

ā€ƒBefore first postoperative chemotherapy

10

9

0.093

Neutropenia

ā€ƒ7Ā days after surgery

0

2

0.54

ā€ƒBefore first postoperative chemotherapy

11

6

0.007*

  1. PMI psoas muscle index
  2. *pā€‰<ā€‰0.05; **pā€‰<ā€‰0.01